Enhancing the efficacy of photodynamic cancer therapy by radicals from plant auxin (indole-3-acetic acid)

Cancer Research

Volumn 63, Issue 4, 2003, Pages 776-779

  Folkes, Lisa K ^a   Wardman, Peter ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUXIN; FREE RADICAL; INDOLEACETIC ACID; METHYLENE BLUE; OXYGEN; PHENOTHIAZINE DERIVATIVE; TOLONIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CANCER; CELL STRAIN MCF 7; CELL STRAIN V 79; DRUG ACTIVATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG OXIDATION; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; REACTION ANALYSIS; RED LIGHT; STRUCTURE ANALYSIS;

ANIMALS; BREAST NEOPLASMS; CELL LINE; CRICETINAE; CRICETULUS; DRUG SYNERGISM; FIBROBLASTS; FREE RADICALS; HUMANS; INDOLEACETIC ACIDS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0037442684     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst., 90: 889-905, 1998.
2. Busch, T. M., Hahn, S. M., Evans, S. M., and Koch, C. J. Depletion of tumour oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3, 3, 3-trifluoropropy)acetamide]. Cancer Res., 60: 2636-2642, 2000.
3. Onofre, M. A., Sposto, M. R., and Navarro, C. M. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endol., 91: 535-540, 2001.
4. Tremblay, J-F., Dussault, S., Viau, G., Gad, F., Boushira, M., and Bissonnette, R. Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis induction. Photochem. Photobiol. Sci., 1: 852-856, 2002.
5. Tuite, E. M., and Kelly, J. M. Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J. Photochem. Photobiol. B, 21: 103-124, 1993.
6. Mellish, K. J., Cox, R. D., Vernon, D. I., Griffiths, J., and Brown, S. B. In vitro photodynamic activity of a series of methylene blue analogues. Photochem. Photobiol., 75: 392-397, 2002.
7. Orth, K., Beck, G., Genze, F., and Rück, A. Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J. Photochem. Photobiol. B, 57: 186-192, 2000.
8. Williams, J. L., Stamp, J., Devonshire, R., and Fowler, G. J. S. Methylene blue and the photodynamic therapy of superficial bladder cancer. J. Photochem. Photobiol. B, 4: 229-232, 1989.
9. Orth, K., Ruck, A., Stenescu, A., and Beger, H. G. Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue. Lancet, 345: 519-520, 1995.
10. Candeias, L. P., Folkes, L. K., Dennis, M. F., Patel, K. B., Everett, S. A., Stratford, M. R. L., and Wardman, P. Free-radical intermediates and stable products in the oxidation of indole-3-acetic acid. J. Phys. Chem., 98: 10131-10137, 1994.
11. Folkes, L. K., and Wardman, P. Oxidative activation of indole-3-acetic acids to cytotoxic species - a potential new role for plant auxins in cancer therapy. Biochem. Pharmacol., 61: 129-136, 2001.
12. Folkes, L. K., Rossiter, S., and Wardman, P. Reactivity toward thiols and cytotoxicity of 3-methylene-2-oxindoles, cytotoxins from indole-3-acetic acids, on oxidation by peroxidases. Chem. Res. Toxicol., 15: 877-882, 2002.
13. Folkes, L. K., Greco, O., Dachs, G. U., Stratford, M. R. L., and Wardman, P. 5-Fluoroindole-3-acetic acid: a prodrug activated by a peroxidase with potential for use in targeted cancer therapy. Biochem. Pharmacol., 63: 265-272, 2002.
14. Stewart, F., Baas, P., and Star, W. What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)? Radiother. Oncol., 48: 233-248, 1998.
15. Mirsky, I. A., and Diengott, D. Hypoglycemic action of indole-3-acetic acid by mouth in patients with diabetes mellitus. Proc. Soc. Exp. Biol. Med., 93: 109-110, 1956.
16. Rysánek, K., and Vitek, V. Increased excretion of 5-hydroxy-indole-acetic acid after administration of 3-indole-acetic acid (heteroauxine). Experientia, 15: 217-218, 1959.
17. Pelgrims, J., De Vos, F., Van den Brande, J., Scrjvers, D., Prové, A., and Vermorken, J. B. Methylene blue in the treatment and prevention of ifosfamide-induced encelphalopathy: report of 12 cases and a review of the literature. Br. J. Cancer, 82: 291-294, 2000.
18. Peter, C., Hongwan, D., Küpfer, A., and Lauterburg, B. H. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur. J. Clin. Pharmacol., 56: 247-250, 2000.
19. Greco, O., Rossiter, S., Kanthou, C., Folkes, L. K., Wardman, P., Tozer, G. M., and Dachs, G. U. Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions. Mol. Cancer Ther., 1: 151-160, 2001.
20. Amat-Guerri, F., Martínez-Utrilla, R., and López-González, M. M. C. Direct and dye-sensitized aqueous photo-oxidation of 3-indoleacetic acid, methyl-3-indoleacetate and 1-methyl-3-indoleacetic acid. I: Analysis of products. J. Photochem. Photobiol. A, 50: 361-375, 1990.
21. Edwards, A. M., Barredo, F., De lonnes, A. E., and Becker, M. I. Apoptosis induction in nonirradiated human HL-60 and murine NSO/2 tumor cells by photoproducts of indole-3-acetic acid and riboflavin. Photochem. Photobiol., 70: 645-649, 1999.